Phase II data presented at APD125 the Annual Meeting of the Associated Professional Sleep Societies show Arena’s 5-HT2a inverse agonist APD-125 to demonstrate efficacy in insomnia
Filed under: Uncategorized | Tagged: 5-HT2A, 5HT2A, agonist, APD-125, APD125, Arena, phase II | Leave a Comment »
